[HTML][HTML] DNA repair pathways in cancer therapy and resistance
L Li, Y Guan, X Chen, J Yang, Y Cheng - Frontiers in pharmacology, 2021 - frontiersin.org
DNA repair pathways are triggered to maintain genetic stability and integrity when
mammalian cells are exposed to endogenous or exogenous DNA-damaging agents. The …
mammalian cells are exposed to endogenous or exogenous DNA-damaging agents. The …
[HTML][HTML] Preclinical evaluation of podoplanin-targeted alpha-radioimmunotherapy with the novel antibody NZ-16 for malignant mesothelioma
The prognosis of advanced mesothelioma is poor. Podoplanin (PDPN) is highly expressed
in most malignant mesothelioma. This study aimed to evaluate the potential alpha …
in most malignant mesothelioma. This study aimed to evaluate the potential alpha …
Miscoding and DNA polymerase stalling by methoxyamine-adducted abasic sites
AV Yudkina, DO Zharkov - Chemical Research in Toxicology, 2022 - ACS Publications
Apurinic/apyrimidinic (AP) sites appear in DNA spontaneously and as intermediates of base
excision DNA repair. AP sites are noninstructive lesions: they strongly block DNA …
excision DNA repair. AP sites are noninstructive lesions: they strongly block DNA …
Vicenin-2: a potential radiosensitizer of non-small cell lung cancer cells
Non-small cell lung cancer (NSCLC) is a major form of cancer and is resistant to chemo-and
radio-therapy. Vicenin-2 (VCN-2) is a flavonoid obtained from Ocimum sanctum L. and it has …
radio-therapy. Vicenin-2 (VCN-2) is a flavonoid obtained from Ocimum sanctum L. and it has …
Therapeutic efficacy evaluation of radioimmunotherapy with 90Y‐labeled anti‐podoplanin antibody NZ‐12 for mesothelioma
H Sudo, AB Tsuji, A Sugyo, T Saga… - Cancer …, 2019 - Wiley Online Library
Podoplanin is a type I transmembrane sialomucin‐like glycoprotein that is highly expressed
in malignant mesothelioma. The rat‐human chimeric antibody NZ‐12 has high affinity for …
in malignant mesothelioma. The rat‐human chimeric antibody NZ‐12 has high affinity for …
Delivery of pemetrexed by magnetic nanoparticles: design, characterization, in vitro and in vivo assessment
G Ak, D Aksu, E Çapkın, Ö Sarı… - Preparative …, 2020 - Taylor & Francis
Drug-loaded magnetic nanoparticles have been developed because of the advantages of
specific drug targeting in cancer treatment. Pemetrexed (PEM) is a multi-targeting antifolate …
specific drug targeting in cancer treatment. Pemetrexed (PEM) is a multi-targeting antifolate …
Adding Base-Excision Repair Inhibitor TRC102 to Standard Pemetrexed–Platinum–Radiation in Patients with Advanced Nonsquamous Non–Small Cell Lung Cancer …
T Biswas, A Dowlati, CA Kunos, JJ Pink… - Clinical Cancer …, 2022 - AACR
Abstract Purpose: TRC102, a small-molecule base-excision repair inhibitor, potentiates the
cytotoxicity of pemetrexed and reverses resistance by binding to chemotherapy-induced …
cytotoxicity of pemetrexed and reverses resistance by binding to chemotherapy-induced …
[HTML][HTML] Combining albumin-binding properties and interaction with pemetrexed to improve the tissue distribution of radiofolates
C Müller, P Guzik, K Siwowska, S Cohrs, RM Schmid… - Molecules, 2018 - mdpi.com
Folic-acid-based radioconjugates have been developed for nuclear imaging of folate
receptor (FR)-positive tumors; however, high renal uptake was unfavorable in view of a …
receptor (FR)-positive tumors; however, high renal uptake was unfavorable in view of a …
[HTML][HTML] SETD2 regulates gene transcription patterns and is associated with radiosensitivity in lung adenocarcinoma
Z Zeng, J Zhang, J Li, Y Li, Z Huang, L Han… - Frontiers in …, 2022 - frontiersin.org
Lung adenocarcinoma (LUAD) has high morbidity and mortality worldwide, and its
prognosis remains unsatisfactory. Identification of epigenetic biomarkers associated with …
prognosis remains unsatisfactory. Identification of epigenetic biomarkers associated with …
[HTML][HTML] Immunotherapy as adjuvant therapy for a patient with adenosquamous carcinoma of the intrahepatic bile duct: A case report and literature review
J Feng, A Yasen, T Dai, R Liang, Z Liao, P He, Z Lin… - Liver Research, 2023 - Elsevier
Adenosquamous carcinoma (ASC) is a rare histological type of intrahepatic
cholangiocarcinoma, which includes both adenocarcinoma and squamous cell carcinoma …
cholangiocarcinoma, which includes both adenocarcinoma and squamous cell carcinoma …